Evidence map›Paper›PMID 32695292›Full record

ArticleIranian journal of basic medical sciences2020

Massood Valizade, Atefeh Raesi Vanani, Mohsen Rezaei, Laya Sadat Khorsandi, Leila Zeidooni, Masoud Mahdavinia

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Proteome of monocled cobra (Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Massood ValizadeCell & Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Atefeh Raesi VananiToxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mohsen RezaeiToxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Laya Sadat KhorsandiCell & Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Leila ZeidooniToxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Masoud MahdaviniaToxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Ahvaz Jundishapur University of Medical Sciences · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe purpose of this study was to investigate cytotoxicity and membrane toxicity effects induced by MATERIALS AND

methodsTo determine the

resultsAccording to MTT and clonogenic assays, MEV caused a significant decrease in cell viability and proliferation of HT-29 cells while it did not have any impact on normal cells and the IC50 value was found to be 10 µg/ml. Induction of apoptosis was also confirmed by flowcytometric analysis in HT-29 cells. Moreover, the results indicated that MEV had led to a suppression of proliferation and induction of apoptosis through increased ROS and depolarization of mitochondria. Furthermore, AFM imaging demonstrated apoptosis cell death after being treated with MEV in HT-29 cells.

conclusionThis study showed that MEV had an antiproliferative effect on HT-29 cells by inducing apoptosis through the mitochondria signaling pathway. These findings suggested that MEV could be used as a promising natural remedy for cancer treatment.

Indexed as

AFMApoptosisHT-29 cancer cellMesobuthus eupeus venomMitochondrial membrane – potentialROS

Identifiers

PMID32695292
PMCPMC7351445
OpenAlexW3026286377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.